Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC)

被引：0

作者：

Pulusu, S. S. R. ^{[1
]}

Srinivasan, A. ^{[2
]}

Krishnaprasad, K. ^{[3
]}

Cheng, D. ^{[4
]}

Mogilevski, T. ^{[5
]}

Flanagan, E. ^{[6
]}

Keung, C. ^{[7
]}

Wu, C. ^{[8
]}

Prosser, R. ^{[9
]}

Sawyer, E. ^{[10
]}

Rizvi, Q. -U. -A. ^{[11
,12
]}

Su, H. ^{[13
]}

Leung, W. -K. ^{[14
]}

Edmundson, A. ^{[3
,14
]}

Cooke, S. ^{[15
]}

Mahy, G. ^{[15
]}

Thin, L. ^{[16
]}

Radford-Smith, G. ^{[3
]}

Sparrow, M. ^{[13
]}

Andrews, J. M. ^{[11
,12
]}

Connor, S. ^{[10
]}

Bampton, P. ^{[9
]}

Ghaly, S. ^{[8
]}

Van Langenberg, D. ^{[7
]}

Bell, S. ^{[6
]}

De Cruz, P. ^{[5
]}

Begun, J. ^{[4
]}

Ng, S. ^{[14
]}

Travis, S. ^{[2
]}

Lawrance, I. ^{[1
]}

机构：

[1] St John God Subiaco, IBD Ctr, Perth, WA, Australia

[2] Oxford Univ Hosp, Oxford, England

[3] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia

[4] Mater Hosp, Brisbane, Qld, Australia

[5] Austin Hlth, Melbourne, Vic, Australia

[6] St Vincents Hosp, Melbourne, Vic, Australia

[7] Eastern Hlth, Melbourne, Vic, Australia

[8] St Vincents Hosp, Sydney, NSW, Australia

[9] Flinders Med Ctr, Adelaide, SA, Australia

[10] Liverpool Hosp, Sydney, NSW, Australia

[11] Royal Adelaide Hosp, Adelaide, SA, Australia

[12] Univ Adelaide, Adelaide, SA, Australia

[13] Alfred Hosp, Melbourne, Vic, Australia

[14] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China

[15] Townsville Hosp, Townsville, Qld, Australia

[16] Fiona Stanley Hosp, Perth, WA, Australia

来源：

JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P571

引用

页码：S395 / S396

页数：2

共 50 条

[21] Vedolizumab for ulcerative colitis:Real world outcomes from a multicenter observational cohort of Australia and Oxford
Samba Siva Reddy Pulusu
Ashish Srinivasan
Krupa Krishnaprasad
Daniel Cheng
Jakob Begun
Charlotte Keung
Daniel Van Langenberg
Lena Thin
Tamara Mogilevski
Peter De Cruz
Graham Radford-Smith
Emma Flanagan
Sally Bell
Soleiman Kashkooli
Miles Sparrow
Simon Ghaly
Peter Bampton
Elise Sawyer
Susan Connor
Quart-ul-ain Rizvi
Jane M Andrews
Gillian Mahy
Paola Chivers
Simon Travis
Ian Craig Lawrance
World Journal of Gastroenterology, 2020, (30) : 4428 - 4441
[22] Vedolizumab Outcomes in Real-world Bio-naive Ulcerative Colitis and Crohn's Disease Patients (EVOLVE) in North America
Yarur, Andres
Bassel, Marielle
Stein, Dara
Kim, Hankyul
Radulescu, Gabriela
Lopez, Claudia
Lissoos, Trevor
Demuth, Dirk
Bressler, Brian
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S374 - S374
[23] Real-world effectiveness of vedolizumab in ulcerative colitis: Week 52 results from the Swedish multi-centre, prospective, observational SVEAH UC study
Eriksson, C.
Rundquist, S.
Lykiardopoulos, V.
Udumyan, R.
Karlen, P.
Grip, O.
Soderman, C.
Almer, S.
Hertervig, E.
Gunnarsson, J.
Malmgren, C.
Delin, J.
Strid, H.
Sjoberg, M.
Oberg, D.
Bergemalm, D.
Hjortswang, H.
Halfvarson, J.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S576 - S577
[24] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN ULCERATIVE COLITIS
Hong, Simon
Zullow, Samantha
Axelrad, Jordan
Chang, Shannon
Hudesman, David
INFLAMMATORY BOWEL DISEASES, 2020, 26 : S73 - S74
[25] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN ULCERATIVE COLITIS
Hong, Simon
Zullow, Samantha
Axelrad, Jordan
Chang, Shannon
Hudesman, David
GASTROENTEROLOGY, 2020, 158 (03) : S120 - S120
[26] Effectiveness and safety of vedolizumab for ulcerative colitis: a single-center retrospective real-world study in China
Huang, Kaituo
Liu, Jing
Xia, Wenhao
Tian, Chuwen
Yao, Lingya
Cao, Qian
Chen, Haotian
FRONTIERS IN PHARMACOLOGY, 2023, 14
[27] Clinical Impact of Vedolizumab Treatment in Patients With Ulcerative Colitis: Evidence from a Real-World Study in Mexico
Aviles, Estefania Contreras
Ponce, Mildred Philippe
Lagunes, Ariadna Guinea
del Prado, Santos Gerardo Almeida
Ocampo, Valeria Natalie Sebastian
Perez, Raquel Yazmin Lopez
Bobadilla, Billy Jimenez
Rendon, Jorge Luis De Leon
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (12S): : S23 - S23
[28] Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis
Adimadhyam, Sruthi
Lewis, James D.
Simon, Andrew L.
Wolfe, Audrey E.
Smith, Samantha
Hou, Laura
Moyneur, Erick
Reynolds, Juliane S.
Toh, Sengwee
Dobes, Angela
Parlett, Lauren
Haynes, Kevin
Burris, Jessica
Dorand, Jennifer E.
Long, Millie D.
Kappelman, Michael D.
INFLAMMATORY BOWEL DISEASES, 2024, 30 (04) : 554 - 562
[29] Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study
Meyer, Antoine
Fumery, Mathurin
Peyrin-Biroulet, Laurent
Filippi, Jerome
Altwegg, Romain
Bouhnik, Yoram
Serrero, Melanie
Laharie, David
Roblin, Xavier
Nachury, Maria
Abitbol, Vered
Cadiot, Guillaume
Nancey, Stephane
Allez, Matthieu
Gilletta, Cyrielle
Vuitton, Lucine
Savoye, Guillaume
Nahon, Stephane
Bourrier, Anne
Buisson, Anthony
Bouguen, Guillaume
Bourreille, Arnaud
Viennot, Stephanie
Carbonnel, Franck
Amiot, Aurelien
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (12) : 1454 - 1462
[30] USTEKINUMAB EXPOSURE AFFECTS REAL-WORLD ENDOSCOPIC AND HISTOLOGIC OUTCOMES IN ULCERATIVE COLITIS
Alsoud, Dahham
Compernolle, Griet
Tops, Sophie
Sabino, Joao
Ferrante, Marc
Thomas, Debby
De Hertogh, Gert
Vermeire, Severine
Verstockt, Bram
GASTROENTEROLOGY, 2022, 162 (07) : S819 - S819

← 1 2 3 4 5 →